The report provides insights into HIV epidemiology, HIV diagnosed patients, and HIV treatment rate for EU5 pharmaceutical markets.
The study measures key indicators such as prevalence of HIV derived from epidemiological analysis, percentage of patients diagnosed with HIV, and percentage of patients treated with a therapy.
The study helps executives estimate HIV market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of HIV prevalence, HIV diagnosis rate, and HIV treatment rate for the period 2016 - 2025.
Key Features of the Report:
- HIV Patient Flow
- HIV Prevalence
- HIV Diagnosed Patients
- HIV Treated Patients
Key Topics Covered:
1. HIV: Disease Definition
2. HIV Patient Flow in Europe
3. HIV Patient Flow in Germany
4. HIV Patient Flow in France
5. HIV Patient Flow in Spain
6. HIV Patient Flow in Italy
7. HIV Patient Flow in UK
For more information about this report visit http://www.researchandmarkets.com/research/pmrbcp/europe_hiv
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/europe-hiv-epidemiology-and-patient-flow-analysis-report-2017-prevalence-diagnosis-rate-and-treatment-rate-2016-2025---research-and-markets-300392788.html
SOURCE Research and Markets